UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors

Human vaccines & immunotherapeutics, 2023-12, Vol.19 (1), p.2177066-2177066

2023

Volltextzugriff (PDF)

Blood pressure control rates with an antihypertensive regimen including trandolapril in a canadian usual-care setting

Advances in therapy, 2011-09, Vol.28 (9), p.789-798

2011

Volltextzugriff (PDF)

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

The New England journal of medicine, 2022-02, Vol.386 (6), p.509-520

2022

Volltextzugriff (PDF)

Obesity in adults: a clinical practice guideline

Canadian Medical Association journal (CMAJ), 2020-08, Vol.192 (31), p.E875-E891

2020

Volltextzugriff (PDF)

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2018-01, Vol.391 (10117), p.219-229

2018

Volltextzugriff (PDF)

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

The Lancet (British edition), 2017-04, Vol.389 (10077), p.1399-1409

2017

Volltextzugriff (PDF)

Effectiveness of a trandolapril-based treatment regimen in subjects with isolated systolic hypertension in Canada

Current medical research and opinion, 2009-06, Vol.25 (6), p.1379-1384

2009

Volltextzugriff (PDF)

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2018-01, Vol.391 (10117), p.205-218

2018

Volltextzugriff (PDF)

The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Journal of the American College of Cardiology, 2017-02, Vol.69 (7), p.777-785

2017

Volltextzugriff (PDF)

A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL)

Clinical therapeutics, 2007-02, Vol.29 (2), p.305-315

2007

Volltextzugriff (PDF)

268-OR: Impact of the COVID-Pandemic on Antihyperglycemic Prescription Patterns in Canada

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

The lancet. Diabetes & endocrinology, 2014-11, Vol.2 (11), p.885-893

2014

Volltextzugriff (PDF)

1241-P: Cross-Sectional Study of the Impact of the COVID-Pandemic on Diabetes Management in Primary Care in Ontario, Canada

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine

Pediatrics (Evanston), 2021-01, Vol.147 (1), p.1

2021

Volltextzugriff (PDF)

Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis

The New England journal of medicine, 2024-10, Vol.391 (17), p.1573-1583

2024

Volltextzugriff (PDF)

A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older (Stride-6)

Clinical infectious diseases, 2024-07

2024

Volltextzugriff (PDF)

Impact of the COVID-19 Pandemic on Antihyperglycemic Prescriptions for Adults With Type 2 Diabetes in Canada: A Cross-sectional Study

Canadian journal of diabetes, 2023-07, Vol.47 (5), p.398-404

2023

Volltextzugriff (PDF)

Impact of the COVID-19 Pandemic on Adults With Type 2 Diabetes Care and Clinical Parameters in a Primary Care Setting in Ontario, Canada: A Cross-sectional Study

Canadian journal of diabetes, 2023-06, Vol.47 (4), p.345-351

2023

Volltextzugriff (PDF)

Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

Clinical research in cardiology, 2022-05, Vol.111 (5), p.560-573

2022

Volltextzugriff (PDF)

Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry

Journal of thrombosis and thrombolysis, 2024-01, Vol.57 (1), p.39-49

2024

Volltextzugriff (PDF)

Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18–49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY)

Open forum infectious diseases, 2022-03, Vol.9 (3), p.ofab605

2022

Volltextzugriff (PDF)

L’obésité chez l’adulte : ligne directrice de pratique clinique

Canadian Medical Association journal (CMAJ), 2020-12, Vol.192 (49), p.E1757-E1775

2020

Volltextzugriff (PDF)

1050. Phase 3 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by 23valent Pneumococcal Polysaccharide Vaccine 6 Months Later in At-risk Adults Aged 18–49 Years (PNEU-DAY): A Subgroup Analysis by Baseline Risk Factors

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S616-S617

2021

Volltextzugriff (PDF)

Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

Clinical research in cardiology, 2022-05, Vol.111 (5), p.593-593

2022

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors

Blood pressure control rates with an antihypertensive regimen including trandolapril in a canadian usual-care setting

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

Obesity in adults: a clinical practice guideline

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Effectiveness of a trandolapril-based treatment regimen in subjects with isolated systolic hypertension in Canada

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL)

268-OR: Impact of the COVID-Pandemic on Antihyperglycemic Prescription Patterns in Canada

Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

1241-P: Cross-Sectional Study of the Impact of the COVID-Pandemic on Diabetes Management in Primary Care in Ontario, Canada

Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine

Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis

A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older (Stride-6)

Impact of the COVID-19 Pandemic on Antihyperglycemic Prescriptions for Adults With Type 2 Diabetes in Canada: A Cross-sectional Study

Impact of the COVID-19 Pandemic on Adults With Type 2 Diabetes Care and Clinical Parameters in a Primary Care Setting in Ontario, Canada: A Cross-sectional Study

Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial

Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry

Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18–49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY)

L’obésité chez l’adulte : ligne directrice de pratique clinique

1050. Phase 3 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by 23valent Pneumococcal Polysaccharide Vaccine 6 Months Later in At-risk Adults Aged 18–49 Years (PNEU-DAY): A Subgroup Analysis by Baseline Risk Factors

Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

Suchergebnisse filtern